Adial Pharmaceuticals, Inc.
ADIL· Nasdaq
ADILAdial Pharmaceuticals, Inc.
Filed Feb 19, 2019 · 10-K · 50 days after period end · 0001213900-19-002769
derived · Computed from the longer spans the company filed.
| Metric | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures |
|---|---|---|
| Net Income | -$1.27M | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Adial Pharmaceuticals, Inc. · CIK 1513525 · Engraved from SEC EDGAR
ended Dec 31, 2018 · filed Feb 19, 2019 · 50 d after period end
